查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1703304

心搏過緩治療設備市場－全球產業規模、佔有率、趨勢、機會和預測（按類型、按設備、按最終用戶、按地區和競爭細分，2020-2030 年）

Bradycardia Treatment Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Devices, By End User, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 187 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球心搏過緩治療設備市場價值為 92.1 億美元，預計到 2030 年將達到 123.8 億美元，預測期內年複合成長率(CAGR) 為 5.03%。這種成長主要是由於心血管疾病發生率的上升和先進起搏器技術的普及。

市場概覽
預測期 2026-2030
2024年市場規模 92.1億美元
2030年市場規模 123.8億美元
2025-2030 年複合年成長率 5.03%
成長最快的領域 竇性心搏過緩
最大的市場 北美洲

心搏過緩的特徵是心率異常緩慢，在老年族群中越來越普遍，對有效治療方案的需求也隨之增加。市場受益於無導線起搏器、MRI 相容設備和遠端監控系統等技術進步，所有這些技術都是為了改善臨床結果並降低併發症的風險。

電生理學和心律管理領域的持續創新進一步加速了心搏過緩治療設備的普及。此外，支持性報銷政策和微創手術技術的進步提高了治療的可近性，促使更多患者尋求治療。

醫療保健投資的增加以及醫療器材製造商和研究機構之間的策略合作也在市場擴張中發揮著至關重要的作用。技術進步，加上人們對早期診斷和介入的認知不斷提高，正在推動進一步的需求。

人工智慧（AI）融入心臟監測系統，顯著提高了心搏過緩檢測的準確性，有利於及時治療。具有更長電池壽命和更高安全性的無線心律調節器正獲得更廣泛的認可，最大限度地減少了重複手術的需要。遠端病人監控正變得越來越普遍，可以即時追蹤心臟健康狀況並更迅速地調整治療。對微創手術的偏好促進了創新心律調節器植入技術的發展，降低了傳統手術通常帶來的風險。

關鍵市場促進因素

心血管疾病盛行率上升

主要市場挑戰

認知有限和診斷不足

主要市場趨勢

植入式裝置的小型化與先進化

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：全球心搏過緩治療設備市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依類型（竇性心搏過緩、竇性停搏、病態竇房結症候群、心搏過速-心搏過緩症候群、心臟傳導阻滯）
    • 按設備（心律調節器{單腔心律調節器、雙腔心律調節器}、除顫器）
    • 按最終使用者（醫院和診所、門診護理中心、其他）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖
    • 按類型
    • 按設備
    • 按最終用戶
    • 按地區

第5章：亞太心搏過緩治療設備市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按類型
    • 按設備
    • 按最終用戶
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 澳洲
    • 日本
    • 韓國

第6章：歐洲心搏過緩治療設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 西班牙
    • 義大利
    • 英國

第7章：北美心搏過緩治療設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
    • 類型
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第8章：南美洲心跳過慢治療設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第9章：中東和非洲心搏過緩治療設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第10章：市場動態

  • 驅動程式
  • 挑戰

第 11 章：市場趨勢與發展

  • 最新動態
  • 產品發布
  • 併購

第 12 章：全球心搏過緩治療設備市場：SWOT 分析

第 13 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 14 章：競爭格局

  • Abbott Laboratories
  • Biotronik
  • Nihon Kohden Corporation
  • Lepu Medical Technology (Beijing)Co Ltd.
  • Medico SRL
  • Oscor Inc
  • Osypka Medical Inc.
  • Microport Scientific Corporation
  • Boston Scientific Corporation
  • Medtronic Plc.

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 16869

Global Bradycardia Treatment Devices Market devices was valued at USD 9.21 billion in 2024 and is projected to reach USD 12.38 billion by 2030, expanding at a compound annual growth rate (CAGR) of 5.03% during the forecast period. This growth is primarily driven by the increasing incidence of cardiovascular diseases and the rising adoption of advanced pacemaker technologies.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 9.21 Billion
Market Size 2030USD 12.38 Billion
CAGR 2025-20305.03%
Fastest Growing SegmentSinus Bradycardia
Largest MarketNorth America

Bradycardia, characterized by an unusually slow heart rate, is increasingly prevalent among the aging population, contributing to a heightened demand for effective treatment solutions. The market is benefiting from technological advancements such as leadless pacemakers, MRI-compatible devices, and remote monitoring systems, all of which are designed to improve clinical outcomes and reduce the risk of complications.

Ongoing innovations in electrophysiology and cardiac rhythm management have further accelerated the adoption of bradycardia treatment devices. Additionally, supportive reimbursement policies and progress in minimally invasive surgical techniques have enhanced accessibility, prompting a greater number of patients to pursue treatment.

Increased healthcare investments and strategic collaborations between medical device manufacturers and research institutions are also playing a vital role in market expansion. Technological advancements, coupled with rising awareness about early diagnosis and intervention, are driving further demand.

The integration of artificial intelligence (AI) into cardiac monitoring systems has significantly enhanced the accuracy of bradycardia detection, facilitating timely treatment. Wireless pacemakers featuring extended battery life and enhanced safety profiles are gaining wider acceptance, minimizing the need for repeated surgical procedures. Remote patient monitoring is becoming increasingly prevalent, enabling real-time tracking of cardiac health and more responsive treatment adjustments. The preference for minimally invasive procedures has fostered the development of innovative pacemaker implantation techniques, reducing the risks typically associated with conventional surgeries.

Key Market Drivers

Rising Prevalence of Cardiovascular Diseases

The increasing global burden of cardiovascular diseases (CVDs) is a major factor propelling growth in the bradycardia treatment devices market. According to the World Health Organization (WHO), CVDs are the leading cause of death worldwide, accounting for approximately 17.9 million fatalities annually. This includes conditions such as heart failure, coronary artery disease, and arrhythmias, with bradycardia being a common manifestation.

The aging global population and increasingly sedentary lifestyles are contributing to a higher incidence of CVDs, expanding the potential patient base for bradycardia treatments. Enhanced diagnostic capabilities and growing awareness of heart-related conditions have empowered healthcare providers to detect and monitor bradycardia more effectively, leading to earlier interventions and greater demand for treatment devices.

Government initiatives and public health strategies aimed at combating cardiovascular diseases are further supporting the adoption of bradycardia treatment technologies. For instance, in Europe, 82% of CVD-related deaths in 2019 were attributed to heart attacks and strokes, highlighting the urgency for preventive care and timely intervention-areas where bradycardia treatment devices play a critical role.

Key Market Challenges

Limited Awareness and Underdiagnosis

A significant barrier to market growth is the limited awareness and underdiagnosis of bradycardia. Despite its potential health implications, the condition often goes unnoticed or is misdiagnosed due to its subtle or intermittent symptoms.

Many individuals with mild bradycardia may not exhibit noticeable signs such as dizziness, fatigue, or fainting, leading them to forgo medical consultation. This contributes to a large number of undiagnosed cases and delays in treatment. Additionally, some healthcare professionals may overlook the more nuanced symptoms of bradycardia, particularly when they occur sporadically, further contributing to underdiagnosis.

Early detection is essential for effective management and the prevention of complications. However, the lack of awareness-both among the general public and within the medical community-remains a critical challenge to the timely identification and treatment of the condition.

Key Market Trends

Miniaturization and Advancement of Implantable Devices

The miniaturization of devices and innovations in implantable technologies are transforming the bradycardia treatment landscape. These trends are central to the advancement of cardiac rhythm management and have significantly enhanced patient outcomes.

Modern pacemakers and implantable cardioverter-defibrillators (ICDs) are now substantially smaller and less obtrusive, making them easier to implant and more comfortable for patients. This reduction in device size contributes to less invasive procedures, faster recovery times, and decreased surgical risk-particularly beneficial for elderly patients or those with higher surgical risks.

Miniaturized devices have also expanded the range of patients eligible for implantation, including those with smaller anatomical structures. Implantable devices now feature advanced functionalities such as adaptive pacing algorithms and remote monitoring capabilities. These features enable healthcare providers to monitor patients' cardiac rhythms in real-time, allowing for timely adjustments and more personalized treatment plans.

Key Market Players

  • Abbott Laboratories
  • Biotronik
  • Nihon Kohden Corporation
  • Lepu Medical Technology (Beijing)Co Ltd.
  • Medico S.R.L.
  • Oscor Inc
  • Osypka Medical Inc.
  • Microport Scientific Corporation
  • Boston Scientific Corporation
  • Medtronic Plc

Report Scope:

In this report, the Global Bradycardia Treatment Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bradycardia Treatment Devices Market, By Type:

  • Sinus Bradycardia
  • Sinus Pause
  • Sick Sinus Syndrome
  • Tachy-brady Syndrome
  • Heart Block

Bradycardia Treatment Devices Market, By Devices:

  • Pacemakers
  • Defibrillator

Bradycardia Treatment Devices Market, By End User:

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

Bradycardia Treatment Devices Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bradycardia Treatment Devices Market.

Available Customizations:

Global Bradycardia Treatment Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Bradycardia Treatment Devices Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share & Forecast
    • 4.2.1. By Type (Sinus Bradycardia, Sinus Pause, Sick Sinus Syndrome, Tachy-brady Syndrome, Heart Block)
    • 4.2.2. By Devices (Pacemakers{Single Chamber Pacemaker, Dual Chamber Pacemaker}, Defibrillator)
    • 4.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
    • 4.2.4. By Region
    • 4.2.5. By Company (2024)
  • 4.3. Market Map
    • 4.3.1. By Type
    • 4.3.2. By Devices
    • 4.3.3. By End User
    • 4.3.4. By Region

5. Asia Pacific Bradycardia Treatment Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type
    • 5.2.2. By Devices
    • 5.2.3. By End User
    • 5.2.4. By Country
  • 5.3. Asia Pacific: Country Analysis
    • 5.3.1. China Bradycardia Treatment Devices Market Outlook
      • 5.3.1.1. Market Size & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share & Forecast
        • 5.3.1.2.1. By Type
        • 5.3.1.2.2. By Devices
        • 5.3.1.2.3. By End User
    • 5.3.2. India Bradycardia Treatment Devices Market Outlook
      • 5.3.2.1. Market Size & Forecast
        • 5.3.2.1.1. By Value
      • 5.3.2.2. Market Share & Forecast
        • 5.3.2.2.1. By Type
        • 5.3.2.2.2. By Devices
        • 5.3.2.2.3. By End User
    • 5.3.3. Australia Bradycardia Treatment Devices Market Outlook
      • 5.3.3.1. Market Size & Forecast
        • 5.3.3.1.1. By Value
      • 5.3.3.2. Market Share & Forecast
        • 5.3.3.2.1. By Type
        • 5.3.3.2.2. By Devices
        • 5.3.3.2.3. By End User
    • 5.3.4. Japan Bradycardia Treatment Devices Market Outlook
      • 5.3.4.1. Market Size & Forecast
        • 5.3.4.1.1. By Value
      • 5.3.4.2. Market Share & Forecast
        • 5.3.4.2.1. By Type
        • 5.3.4.2.2. By Devices
        • 5.3.4.2.3. By End User
    • 5.3.5. South Korea Bradycardia Treatment Devices Market Outlook
      • 5.3.5.1. Market Size & Forecast
        • 5.3.5.1.1. By Value
      • 5.3.5.2. Market Share & Forecast
        • 5.3.5.2.1. By Type
        • 5.3.5.2.2. By Devices
        • 5.3.5.2.3. By End User

6. Europe Bradycardia Treatment Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Devices
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. Europe: Country Analysis
    • 6.3.1. France Bradycardia Treatment Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Devices
        • 6.3.1.2.3. By End User
    • 6.3.2. Germany Bradycardia Treatment Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Devices
        • 6.3.2.2.3. By End User
    • 6.3.3. Spain Bradycardia Treatment Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Devices
        • 6.3.3.2.3. By End User
    • 6.3.4. Italy Bradycardia Treatment Devices Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Type
        • 6.3.4.2.2. By Devices
        • 6.3.4.2.3. By End User
    • 6.3.5. United Kingdom Bradycardia Treatment Devices Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Type
        • 6.3.5.2.2. By Devices
        • 6.3.5.2.3. By End User

7. North America Bradycardia Treatment Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Drug Type
    • 7.2.2. Type
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Bradycardia Treatment Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Devices
        • 7.3.1.2.3. By End User
    • 7.3.2. Mexico Bradycardia Treatment Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Devices
        • 7.3.2.2.3. By End User
    • 7.3.3. Canada Bradycardia Treatment Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Devices
        • 7.3.3.2.3. By End User

8. South America Bradycardia Treatment Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Devices
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. South America: Country Analysis
    • 8.3.1. Brazil Bradycardia Treatment Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Devices
        • 8.3.1.2.3. By End User
    • 8.3.2. Argentina Bradycardia Treatment Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Devices
        • 8.3.2.2.3. By End User
    • 8.3.3. Colombia Bradycardia Treatment Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Devices
        • 8.3.3.2.3. By End User

9. Middle East and Africa Bradycardia Treatment Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Devices
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. MEA: Country Analysis
    • 9.3.1. South Africa Bradycardia Treatment Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Devices
        • 9.3.1.2.3. By End User
    • 9.3.2. Saudi Arabia Bradycardia Treatment Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Devices
        • 9.3.2.2.3. By End User
    • 9.3.3. UAE Bradycardia Treatment Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Devices
        • 9.3.3.2.3. By End User

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

  • 11.1. Recent Developments
  • 11.2. Product Launches
  • 11.3. Mergers & Acquisitions

12. Global Bradycardia Treatment Devices Market: SWOT Analysis

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Product

14. Competitive Landscape

  • 14.1. Abbott Laboratories
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Current Capacity Analysis
    • 14.1.5. Financials (In case of listed)
    • 14.1.6. Recent Developments
    • 14.1.7. SWOT Analysis
  • 14.2. Biotronik
  • 14.3. Nihon Kohden Corporation
  • 14.4. Lepu Medical Technology (Beijing)Co Ltd.
  • 14.5. Medico S.R.L.
  • 14.6. Oscor Inc
  • 14.7. Osypka Medical Inc.
  • 14.8. Microport Scientific Corporation
  • 14.9. Boston Scientific Corporation
  • 14.10.Medtronic Plc.

15. Strategic Recommendations

16. About Us & Disclaimer